Mark Hancock, Co-Founder and Executive Vice Chair of PACS Group, Inc. (NASDAQ:PACS), executed a significant divestment of company equity on June 17, 2026. The transaction involved the disposal of 63,680 shares of common stock, with a total realized value of approximately $2.25 million. These sales were conducted under the framework of a Rule 10b5-1 trading plan, which Hancock established on March 11, 2026. The shares were liquidated at prices ranging from $34.6757 to $36.0685 per share. Specifically, 60,364 shares were sold at a weighted average price of $35.2838, with individual transaction prices between $34.6757 and $35.67. An additional 3,316 shares were sold at a weighted average price of $35.7491, with individual transaction prices ranging from $35.6799 to $36.0685. The total value of these sales amounted to $2,248,415. Following these transactions, Mr. Hancock directly holds 54,302,597 shares of PACS Group common stock.
The insider sale comes as PACS stock trades at $37.77, up 187% over the past year. According to InvestingPro analysis, the stock appears overvalued at current levels. For deeper insights, investors can access a comprehensive Pro Research Report covering PACS—one of 1,400+ US equities analyzed on the platform.
In other recent news, PACS Group reported impressive financial results for the first quarter of 2026. The company exceeded earnings expectations with an earnings per share (EPS) of $0.50, compared to the forecasted $0.44, resulting in a 13.64% surprise. Revenue for the quarter reached $1.42 billion, reflecting an 11% increase from the previous year. These results highlight PACS Group’s robust performance and strong market position. In addition, Truist Securities reiterated its Buy rating on PACS Group, setting a price target of $52.00. The firm emphasized the company’s strong demand trends and effective execution strategies. Truist also noted PACS Group’s ongoing investments focused on regulatory compliance. These developments underscore the company’s solid footing in the market.